SET8 expression is associated with overall survival in gastric cancer

Genetics and Molecular Research

Volumn 14, Issue 4, 2015, Pages 15609-15615

  Shi, X L ^a   Guo, Z J ^a   Wang, X L ^a   Liu, X L ^a   Shi, G F ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Cancer survival; Gastric cancer; Predictor; SET8

Indexed keywords

SET8 PROTEIN; TUMOR PROTEIN; UNCLASSIFIED DRUG; HISTONE LYSINE METHYLTRANSFERASE; SETD8 PROTEIN, HUMAN;

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER RISK; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION; GENE FUNCTION; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTIVE VALUE; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RISK ASSESSMENT; RISK FACTOR; SET8 GENE; STOMACH CANCER; STOMACH CARCINOGENESIS; SURVIVAL RATE; SURVIVAL TIME; TUMOR GENE; AGED; CANCER STAGING; GENETICS; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PROGNOSIS; STOMACH NEOPLASMS; TUMOR VOLUME;

ADULT; AGED; COMBINED MODALITY THERAPY; FEMALE; GENE EXPRESSION; HISTONE-LYSINE N-METHYLTRANSFERASE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; STOMACH NEOPLASMS; TUMOR BURDEN;

EID: 84962785249     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2015.December.1.12     Document Type: Article

References (24)

1. Abbas T, Shibata E, Park J, Jha S, et al. (2010). CRL4(Cdt2) regulates cell proliferation and histone gene expression by targeting PR-Set7/Set8 for degradation. Mol. Cell 40: 9-21.
2. Ali Z, Deng Y, Tang Y, Zheng S, et al. (2013). Epigenetic deregulations in gastric cancer. J. Nanosci. Nanotechnol. 13: 40-51.
3. Centore RC, Havens CG, Manning AL, Li JM, et al. (2010). CRL4(Cdt2)-mediated destruction of the histone methyltransferase Set8 prevents premature chromatin compaction in S phase. Mol. Cell 40: 22-33.
4. Ding C, Li R, Peng J, Li S, et al. (2012). A polymorphism at the miR-502 binding site in the 3' untranslated region of the SET8 gene is associated with the outcome of small-cell lung cancer. Exp. Ther. Med. 3: 689-692.
5. Ding WJ, Fang JY, Chen XY and Peng YS (2008). The expression and clinical significance of DNA methyltransferase proteins in human gastric cancer. Dig. Dis. Sci. 53: 2083-2089.
6. Fang J, Feng Q, Ketel CS, Wang H, et al. (2002). Purification and functional characterization of SET8, a nucleosomal histone H4-lysine 20-specific methyltransferase. Curr. Biol. 12: 1086-1099.
7. Fraga MF, Ballestar E, Villar-Garea A, Boix-Chornet M, et al. (2005). Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat. Genet. 37: 391-400.
8. Guo Z, Wu C, Wang X, Wang C, et al. (2012). A polymorphism at the miR-502 binding site in the 3'-untranslated region of the histone methyltransferase SET8 is associated with hepatocellular carcinoma outcome. Int. J. Cancer 131: 1318-1322.
9. Jemal A, Bray F, Center MM, Ferlay J, et al. (2011). Global cancer statistics. CA Cancer J. Clin. 61: 69-90.
10. Jones PA and Baylin SB (2007). The epigenomics of cancer. Cell 128: 683-692.
11. Jørgensen S, Eskildsen M, Fugger K, Hansen L, et al. (2011). SET8 is degraded via PCNA-coupled CRL4(CDT2) ubiquitylation in S phase and after UV irradiation. J. Cell Biol. 192: 43-54.
12. Kachirskaia I, Yamaguchi H, West LE, Wen H, et al. (2007). Modulation of p53 function by SET8-mediated methylation at lysine382. Mol. Cell 27: 636-646.
13. Lacroix M, Toillon RA and Leclercq G (2006). p53 and breast cancer, an update. Endocr. Relat. Cancer 13: 293-325.
14. Li Z, Nie F, Wang S and Li L (2011). Histone H4 Lys 20 monomethylation by histone methylase SET8 mediates Wnt target gene activation. Proc. Natl. Acad. Sci. U. S. A. 108: 3116-3123.
15. Merritt WM, Lin YG, Han LY, Kamat AA, et al. (2008). Dicer, Drosha, and outcomes in patients with ovarian cancer. N. Engl. J. Med. 359: 2641-2650.
16. Miyahara R, Niwa Y, Matsuura T, Maeda O, et al. (2007). Prevalence and prognosis of gastric cancer detected by screening in a large Japanese population: data from a single institute over 30 years. J. Gastroenterol. Hepatol. 22: 1435-1442.
17. Nishioka K, Rice JC, Sarma K, Erdjument-Bromage H, et al. (2002). PR-Set7 is a nucleosome-specific methyltransferase that modifies lysine 20 of histone H4 and is associated with silent chromatin. Mol. Cell 9: 1201-1213.
18. Oda H, Hübner MR, Beck DB, Vermeulen M, et al. (2010). Regulation of the histone H4 monomethylase PR-Set7 by CRL4(Cdt2)-mediated PCNA-dependent degradation during DNA damage. Mol. Cell 40: 364-376.
19. Papazoglu C and Mills AA (2007). p53: at the crossroad between cancer and ageing. J. Pathol. 211: 124-133.
20. Song F, Zheng H, Liu B, Wei S, et al. (2009). An miR-502-binding site single-nucleotide polymorphism in the 3'-untranslated region of the SET8 gene is associated with early age of breast cancer onset. Clin. Cancer Res. 15: 6292-6300.
21. Tahara E (1995). Genetic alterations in human gastrointestinal cancers. The application to molecular diagnosis. Cancer 75: 1410-1417.
22. Wang C, Guo Z, Wu C, Li Y, et al. (2012). A polymorphism at the miR-502 binding site in the 3' untranslated region of the SET8 gene is associated with the risk of epithelial ovarian cancer. Cancer Genet. 205: 373-376.
23. Xu J, Yin Z, Gao W, Liu L, et al. (2013). Genetic variation in a microRNA-502 binding site in SET8 gene confers clinical outcome of non-small cell lung cancer in a Chinese population. PLoS One 8: e77024.
24. Yu Z, Li Z, Jolicoeur N, Zhang L, et al. (2007). Aberrant allele frequencies of the SNPs located in microRNA target sites are potentially associated with human cancers. Nucleic Acids Res. 35: 4535-4541.